A phase Ib, placebo-controlled randomized clinical trial of the Ebolavirus DNA vaccine candidate INO-4201 followed by electroporation as booster vaccination in healthy, rVSVDeltaG-ZEBOV-GP-primed volunteers (Boost-EBOV). (linkinghub.elsevier.com)

Authors: Huttner A … Kobinger GP Journal: Clinical Microbiology and Infection Published: 2026-01-27 DOI: https://doi.org/10.1016/j.cmi.2026.01.019